Jong-Ho Park1, Bruce Ovbiagele2. 1. Department of Neurology, Seonam University Myongji Hospital, Goyang, South Korea. 2. Department of Neurology, Medical University of South Carolina, Charleston, SC, USA. Electronic address: Ovibes@musc.edu.
Abstract
BACKGROUND: The significantly higher risk of primary stroke in Black vs. Whites is very well established. However, very few studies have specifically examined the presence of this racial disparity in recurrent stroke risk. METHODS: We conducted an analysis of a clinical trial dataset comprising 3470 recent non-cardioembolic stroke patients aged ≥35years and followed for 2years. Subjects were categorized by race into Whites and Blacks. Cox regression analysis was used to evaluate the associations between Black (vs. White) and ischemic stroke (primary outcome); and stroke/coronary heart disease (CHD)/vascular death as major vascular events (secondary outcome) with and without adjustment for comorbid conditions associated with stroke. RESULTS: Among participants (2925 Whites and 545 Blacks), a total of 287 (8.3%) incident stroke and 582 (16.8%) major vascular events occurred. Compared with Whites, Blacks had higher frequencies of prior stroke, hypertension, diabetes mellitus, and smoking; but were younger with lower prevalence of CHD. Frequency of stroke was higher in Blacks vs. Whites (11.4% vs. 7.7%; P=0.004), but there was no difference in major vascular events (16.9% vs. 16.8%). Compared with Whites, Blacks experienced a significantly higher risk of recurrent stroke (HR 1.58; 95% CI, 1.19-2.09), but the stroke risk was not significant after multivariable adjustment (1.13; 0.81-1.59). CONCLUSION: Blacks are ~60% more likely to experience a recurrent stroke within 2years than their Whites, but this risk is likely mediated via stroke risk factors. These results underscore a need to optimize and sustain risk factor control in Black stroke populations.
BACKGROUND: The significantly higher risk of primary stroke in Black vs. Whites is very well established. However, very few studies have specifically examined the presence of this racial disparity in recurrent stroke risk. METHODS: We conducted an analysis of a clinical trial dataset comprising 3470 recent non-cardioembolic strokepatients aged ≥35years and followed for 2years. Subjects were categorized by race into Whites and Blacks. Cox regression analysis was used to evaluate the associations between Black (vs. White) and ischemic stroke (primary outcome); and stroke/coronary heart disease (CHD)/vascular death as major vascular events (secondary outcome) with and without adjustment for comorbid conditions associated with stroke. RESULTS: Among participants (2925 Whites and 545 Blacks), a total of 287 (8.3%) incident stroke and 582 (16.8%) major vascular events occurred. Compared with Whites, Blacks had higher frequencies of prior stroke, hypertension, diabetes mellitus, and smoking; but were younger with lower prevalence of CHD. Frequency of stroke was higher in Blacks vs. Whites (11.4% vs. 7.7%; P=0.004), but there was no difference in major vascular events (16.9% vs. 16.8%). Compared with Whites, Blacks experienced a significantly higher risk of recurrent stroke (HR 1.58; 95% CI, 1.19-2.09), but the stroke risk was not significant after multivariable adjustment (1.13; 0.81-1.59). CONCLUSION: Blacks are ~60% more likely to experience a recurrent stroke within 2years than their Whites, but this risk is likely mediated via stroke risk factors. These results underscore a need to optimize and sustain risk factor control in Black stroke populations.
Authors: Dawn Kleindorfer; Joseph Broderick; Jane Khoury; Matthew Flaherty; Daniel Woo; Kathleen Alwell; Charles J Moomaw; Alexander Schneider; Rosie Miller; Rakesh Shukla; Brett Kissela Journal: Stroke Date: 2006-08-31 Impact factor: 7.914
Authors: Dawn M Bravata; Carolyn K Wells; Barbara Gulanski; Walter N Kernan; Lawrence M Brass; Judith Long; John Concato Journal: Stroke Date: 2005-06-16 Impact factor: 7.914
Authors: George Howard; Ron Prineas; Claudia Moy; Mary Cushman; Martha Kellum; Ella Temple; Andra Graham; Virginia Howard Journal: Stroke Date: 2006-03-23 Impact factor: 7.914
Authors: Mary Cushman; Ronald A Cantrell; Leslie A McClure; George Howard; Ronald J Prineas; Claudia S Moy; Ella M Temple; Virginia J Howard Journal: Ann Neurol Date: 2008-11 Impact factor: 10.422
Authors: Pierre Amarenco; Julien Bogousslavsky; Alfred Callahan; Larry B Goldstein; Michael Hennerici; Amy E Rudolph; Henrik Sillesen; Lisa Simunovic; Michael Szarek; K M A Welch; Justin A Zivin Journal: N Engl J Med Date: 2006-08-10 Impact factor: 91.245
Authors: Catherine C Cowie; Keith F Rust; Danita D Byrd-Holt; Edward W Gregg; Earl S Ford; Linda S Geiss; Kathleen E Bainbridge; Judith E Fradkin Journal: Diabetes Care Date: 2010-01-12 Impact factor: 19.112
Authors: James F Toole; M René Malinow; Lloyd E Chambless; J David Spence; L Creed Pettigrew; Virginia J Howard; Elizabeth G Sides; Chin-Hua Wang; Meir Stampfer Journal: JAMA Date: 2004-02-04 Impact factor: 56.272
Authors: Karen C Albright; Lei Huang; Justin Blackburn; George Howard; Michael Mullen; Vera Bittner; Paul Muntner; Virginia Howard Journal: Neurology Date: 2018-10-03 Impact factor: 9.910
Authors: Neco X Johnson; Maria J Marquine; Ilse Flores; Anya Umlauf; Carolyn M Baum; Alex W K Wong; Alexis C Young; Jennifer J Manly; Allen W Heinemann; Susan Magasi; Robert K Heaton Journal: J Int Neuropsychol Soc Date: 2017-06-29 Impact factor: 2.892
Authors: Hammad Ghanchi; Tye Patchana; James Wiginton; Jonathan D Browne; Ai Ohno; Ronit Farahmandian; Jason Duong; Vladimir Cortez; Dan E Miulli Journal: Cureus Date: 2020-09-10
Authors: Carolyn H Still; Chris Burant; Shirley Moore; Doug Einstadter; Cheryl Killion; Charles Modlin; Sophia Sundararajan; John D Thornton; Jackson T Wright; Martha Sajatovic Journal: J Multidiscip Healthc Date: 2021-02-23
Authors: Hooman Kamel; Cenai Zhang; Dawn O Kleindorfer; Emily B Levitan; Virginia J Howard; George Howard; Elsayed Z Soliman; S Claiborne Johnston Journal: JAMA Neurol Date: 2020-05-01 Impact factor: 18.302